STT Gelatinase Inhibitor modification, negative control

STT Gelatinase Inhibitor modification, negative control, carries an altered sequence that disrupts gelatinase binding while preserving physicochemical properties. Randomized or substituted residues prevent productive inhibitory contacts. Structural behavior provides a baseline for specificity assessment. The peptide is useful for validating matrix metalloproteinase assays and non-specific interactions.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: C08204

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.W/Mr.
1136.2
Sequence
STTHWGFTLS
Length
10

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Nucleic Acids SynthesisPeptide Modification ServicesPeptide Analysis ServicesPeptide CDMOCustom Conjugation ServicePeptide Synthesis ServicescGMP Peptide ServiceEpitope Mapping Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers